stockrowMyriad Genetics, Inc. (MYGN) vs OPKO Health, Inc. (OPK)
- Myriad Genetics, Inc. MYGN 5.95 −5.41%
- OPKO Health, Inc. OPK 1.74 −0.57%
Myriad Genetics, Inc. and OPKO Health, Inc. are both Diagnostics & Research companies. OPKO Health, Inc. is the larger, with a market value of $1.3B against $601.6M — 2.2× the size. Myriad Genetics, Inc. grew revenue faster over the last twelve months: −3.16% against −21.9%. Myriad Genetics, Inc. has the higher net margin (−14.0% vs −29.5%) and the lower return on invested capital (−19.9% vs −6.72%). Across the 18 metrics below, Myriad Genetics, Inc. leads on 11 and OPKO Health, Inc. on 7.
Valuation
Profitability
| Metric | MYGN | OPK | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 68.83% | 46.22% | 48.32% |
| Operating margin | (12.22%) | (25.46%) | (5.68%) |
| Net margin | (13.96%) | (29.51%) | (4.10%) |
| Free cash flow margin | (1.76%) | (26.91%) | 0.00% |
| Return on equity | (32.54%) | (12.23%) | 0.00% |
| Return on assets | (17.11%) | (7.64%) | (6.05%) |
| Return on invested capital | (19.92%) | (6.72%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack